SPARTARI

Serial Number 88671008
606

Registration Progress

Application Filed
Oct 28, 2019
Under Examination
May 5, 2020
Approved for Publication
Mar 10, 2020
Published for Opposition
Mar 10, 2020
Registered

Trademark Image

SPARTARI

Basic Information

Serial Number
88671008
Filing Date
October 28, 2019
Published for Opposition
March 10, 2020
Abandonment Date
June 7, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 7, 2021
Classes
005

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

Retrophin, Inc.

Owner at Publication
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner After Publication #1
03
SAN DIEGO, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jun 7, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 7, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 17, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 5, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 10, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 10, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 19, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 6, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 3, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 31, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis

Classification

International Classes
005